Original article by Joyce Moullakis
The Australian Financial Review – Page: 13 & 16 : 13-Aug-18

The value of announced mergers and acquisitions involving Australian-listed companies has topped US$39.3bn so far in 2018. Private equity investors have been particularly active; US$11.4bn ($15.6bn) worth of such deals involving both listed and unlisted assets have been announced so far in 2018, which is 47 per cent higher than at the same time in 2017. Experts anticipate that the private equity sector will continue to pursue listed companies, with Tom Story of law firm Allens noting that suitors and their targets have been more willing to agree on price in 2018.

CORPORATES
ALLENS, DEALOGIC (AUSTRALIA) PTY LTD, INVESTA OFFICE FUND – ASX IOF, THE BLACKSTONE GROUP LP, SIRTEX MEDICAL LIMITED – ASX SRX, CDH INVESTMENTS FUND MANAGEMENT COMPANY, BWX LIMITED – ASX BWX, SINO GAS AND ENERGY HOLDINGS LIMITED – ASX SEH, SANTOS LIMITED – ASX STO, HEALTHSCOPE LIMITED – ASX HSO, OAKTREE CAPITAL MANAGEMENT LLC, BILLABONG INTERNATIONAL LIMITED, PACIFIC EQUITY PARTNERS PTY LTD, LIFEHEALTHCARE PTY LTD, CITIGROUP PTY LTD, BGH CAPITAL PTY LTD, BAIN AND COMPANY, I-MED RADIOLOGY, ACCOLADE WINES LIMITED, CHAMP PRIVATE EQUITY PTY LTD, THE CARLYLE GROUP, MANUKA HEALTH, IXOM, PEMBA CAPITAL, DEVICE TECHNOLOGIES AUSTRALIA, GOLDMAN SACHS AUSTRALIA PTY LTD, UBS HOLDINGS PTY LTD, AMCOR LIMITED – ASX AMC, NEW YORK STOCK EXCHANGE